PPT-Access to essential medicines for NCDs

WHO EMP and NVI Departments Access to NCD essential medicines on the global agenda Access to chronic disease medicines is required for the fulfilment of MDG8 Governments in collaboration with the private sector should give greater priority to treating chronic diseases and improving the accessibility of medicines to treat them MDG Report 2009. Concept and Process. IPC Meeting. June 6, 2014 – WHO Geneva. Nicola Magrini – WHO, EMP. Essential Medicines. Guiding principle:. . A limited range of carefully selected essential medicines leads to better health care, better medicines management, and lower costs. for asthma. WHO . Technical. Briefing . Seminar. on Essential . Medicines. & Health . Products. , Nov. 2013. Christophe Perrin, . Pharmacist. , MPH – IUATLD (The Union). Asthma. . - Global . Noncommunicable Diseases –Action Plan . . Dr Shanthi Mendis . Director, Department of NCD Management a.i.. World Health Organization. Geneva, Switzerland. for asthma. WHO . Technical. Briefing . Seminar. on Essential . Medicines. & Health . Products. , Nov. 2013. Christophe Perrin, . Pharmacist. , MPH – IUATLD (The Union). Asthma. . - Global . Gilles Forte. Policy. , Access and Use Team. Department for Essential . Medicines and Health Products. World Health Assembly Resolution 67.22 . Access . to essential medicines. Recognize . the importance of effective national medicines policies, and their . Gilles . Forte. Coordinator, Policy, Access and Use Team. Essential . Medicines . and . Health Products. . WHO . mandate . within the . International . Drug Control Conventions. 1961 . Single Convention on Narcotic Drugs (Article 3). IPC Meeting . 4 to 6 . June. 2014. Essential Medicines and Health Products Department (EMP) . . . October. 2013. . Office of the . Concept and Process. IPC Meeting. June 6, 2014 – WHO Geneva. Nicola Magrini – WHO, EMP. Essential Medicines. Guiding principle:. . A limited range of carefully selected essential medicines leads to better health care, better medicines management, and lower costs. for asthma. WHO . Technical. Briefing . Seminar. on Essential . Medicines. & Health . Products. , Nov. 2013. Christophe Perrin, . Pharmacist. , MPH – IUATLD (The Union). Asthma. . - Global . Noncommunicable Diseases –Action Plan . . Dr Shanthi Mendis . Director, Department of NCD Management a.i.. World Health Organization. Geneva, Switzerland. Dr Cécile . Macé. . WHO EMP , Mr Arne-Petter . Sanne. WHO MND, . Mr . Ajuebor. Onyema WHO MND. NCD Programme Managers Seminar. 4 June 2014. Access to NCD essential medicines . on the global agenda. IPC Meeting . 4 to 6 . June. 2014. Essential Medicines and Health Products Department (EMP) . . . October. 2013. . Office of the . Case Management. George Jagoe . EVP, Access & Product Management, MMV. . . The access team at MMV is heavily focused on the needs of control today. 4. Achieving patient impact means addressing many hurdles to access. Concept and Process. IPC Meeting. June 6, 2014 – WHO Geneva. Nicola Magrini – WHO, EMP. Essential Medicines. Guiding principle:. . A limited range of carefully selected essential medicines leads to better health care, better medicines management, and lower costs.